WTO declines to waive TRIPS provisions for COVID-19 drugs
25-01-2021
South Africa, India urge WTO to waive IP for COVID-19 treatments
08-10-2020
WTO 'expected to announce' 17-year drug patent waiver for LDCs
04-11-2015
EQroy / Shutterstock.com
Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation (WTO) to conclude an agreement.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
COVID-19, World Trade Organization, IP, TRIPS, drugs, UK, India, South Africa, vaccines
